SCHEMBL17510202

SCHEMBL17510202

[O]CCOCc1nn(Cc2ccccc2)c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC16A3 O15427 1/20 0.59
▸ CNR1 P21554 4/20 0.53
▸ CNR2 P34972 4/20 0.53
▸ ACHE P22303 3/20 0.53
▸ SCN8A Q9UQD0 2/20 0.47
▸ CYP1A2 P05177 3/20 0.46
▸ CYP2D6 P10635 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ GUCY1B2 O75343 1/20 0.46
▸ CHRM2 P08172 1/20 0.46
▸ HTR1A P08908 1/20 0.46
▸ ADRA2A P08913 1/20 0.46
▸ CHRM1 P11229 1/20 0.46
▸ DRD1 P21728 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A4 P31645 1/20 0.46
▸ GUCY1A2 P33402 1/20 0.46
▸ ADRA1A P35348 1/20 0.46
▸ OPRM1 P35372 1/20 0.46
▸ DRD3 P35462 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22849936 0.89 SLC16A3 (0.64) SLC16A3CNR1CNR2ACHESCN8A
SCHEMBL929060 0.86 SLC16A3 (0.59) SLC16A3CNR1CNR2ACHESCN8A
SCHEMBL929474 0.85 SLC16A3 (0.61) SLC16A3CNR1CNR2ACHESCN8A
SCHEMBL29562290 0.84 SLC16A3 (0.57) SLC16A3CNR1CNR2ACHESCN8A
SCHEMBL927053 0.84 SLC16A3 (0.57) SLC16A3CNR1CNR2ACHESCN8A
SCHEMBL22849913 0.83 SLC16A3 (0.62) SLC16A3CNR1CNR2ACHESCN8A
SCHEMBL1603187 0.83 CYP1A2 (0.61) SLC16A3CNR1CNR2ACHESCN8A
SCHEMBL927728 0.83 SLC16A3 (0.58) SLC16A3CNR1CNR2ACHESCN8A
SCHEMBL1652008 0.83 SLC16A3 (0.58) SLC16A3CNR1CNR2ACHESCN8A
Hydrochloric Acid SCHEMBL1603361 0.82 POLB (0.62) SLC16A3CNR1CNR2ACHESCN8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254870-B1 1-BENZYL-3-HYDROXYMETHYLINDAZOLE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 ACRAF (IT) 2016-02-24 — — EP disclosed
Send feedback